Stents Archives - PharmaLive

Abbott’s Xience Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients

Abbott, Approvals, Bleeding, Blood Thinner, Clinical Trials, FDA, R&D, Stents

Abbott’s Xience family of stents received U.S. Food and Drug Administration approval for one-month (as short as 28 days) dual anti-platelet therapy labeling for high bleeding risk patients in the United States.

“Dueling Numbers”: FDA Panel Trying to Determine Safety of Paclitaxel-Coated Stents and Balloons

Balloons, FDA, FDA/Regulatory, Mortality rates, Stents

The U.S. FDA’s Circulatory System Devices Panel is undergoing two days of presentations and meetings regarding mortality rates associated with the use of paclitaxel-coated balloons and paclitaxel-eluting stents.

Newest Generation Of Leading Heart Stent Approved In U.S. For People With Coronary Artery Disease

Approvals, FDA, Medical Devices, Stents

Abbott received approval from the U.S. Food and Drug Administration for XIENCE Sierra, the newest generation of the gold-standard XIENCE everolimus-eluting coronary stent system.